Notable Labs Total Liabilities 2013-2024 | NTBLQ

Notable Labs total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Notable Labs Annual Total Liabilities
(Millions of US $)
2023 $4
2022 $42
2021 $14
2020 $11
2019 $13
2018 $8
2017 $10
2016 $5
2015 $4
2014 $3
2013 $35
2012 $0
Notable Labs Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $4
2024-03-31 $4
2023-12-31 $4
2023-09-30 $3
2023-06-30 $5
2023-03-31 $8
2022-12-31 $42
2022-09-30 $10
2022-06-30 $11
2022-03-31 $13
2021-12-31 $14
2021-09-30 $12
2021-06-30 $13
2021-03-31 $11
2020-12-31 $11
2020-09-30 $11
2020-06-30 $10
2020-03-31 $12
2019-12-31 $13
2019-09-30 $12
2019-06-30 $12
2019-03-31 $11
2018-12-31 $8
2018-09-30 $8
2018-06-30 $9
2018-03-31 $10
2017-12-31 $10
2017-09-30 $5
2017-06-30 $6
2017-03-31 $5
2016-12-31 $5
2016-09-30 $4
2016-06-30 $4
2016-03-31 $4
2015-12-31 $4
2015-09-30 $5
2015-06-30 $3
2015-03-31 $3
2014-12-31 $3
2014-09-30 $6
2014-06-30 $0
2014-03-31 $0
2013-12-31 $35
2013-09-30
2012-12-31 $0
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00